Skip to main content
ZJAMP Group Co., Ltd. logo

ZJAMP Group Co., Ltd. — Investor Relations & Filings

Ticker · 002758 ISIN · CNE100002029 LEI · 3003009OKT32LB5C0T64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,563 across all filing types
Latest filing 2020-07-21 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002758

About ZJAMP Group Co., Ltd.

https://www.znjtgf.com

ZJAMP Group Co., Ltd. specializes in the comprehensive distribution and supply chain management of agricultural production materials. The company’s core operations encompass the procurement, storage, and sale of essential inputs, including chemical fertilizers such as urea, potash, and compound fertilizers, as well as pesticides, seeds, and agricultural machinery. Beyond product distribution, the organization provides integrated technical services, modern logistics solutions, and agricultural consultancy to enhance crop yields and farming efficiency. By leveraging an extensive network of distribution centers and service stations, the group facilitates the stable supply of high-quality agricultural resources. Its business model focuses on bridging the gap between manufacturers and end-users through efficient resource allocation and value-added services.

Recent filings

Filing Released Lang Actions
关于使用部分暂时闲置募集资金到期赎回并继续进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Zhejiang Huatong Pharmaceutical Co., Ltd. regarding the use of temporarily idle raised funds for cash management, specifically the purchase and redemption of structured deposits. It details the amounts, dates, yields, and risk controls related to these financial products. The document is a progress announcement about the company's cash management activities using idle raised funds, not a full financial report or earnings release. It is relatively short (4454 characters) and focuses on specific financing and investment activities rather than comprehensive financial results or management discussion. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2020-07-21 Chinese
2020年第二季度可转换公司债券转股情况公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the convertible bonds (可转换公司债券) of Zhejiang Huatong Pharmaceutical Co., Ltd. It details the convertible bond issuance, conversion price adjustments, conversion activity during the second quarter of 2020, and changes in shareholding due to bond conversions. The document includes specific bond codes, stock codes, conversion prices, and shareholding changes. It is a regulatory announcement about bond conversion and share changes rather than a full financial report or earnings release. The document length is about 2064 characters, which is relatively short and focused on a specific capital market event. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as convertible bond conversions and related share changes.
2020-07-01 Chinese
发行股份购买资产暨关联交易报告书（修订稿）摘要
Capital/Financing Update Classification · 95% confidence The document is a detailed report titled "浙江华通医药股份有限公司 发行股份购买资产暨关联交易报告书（修订稿）摘要" which translates to "Zhejiang Huatong Pharmaceutical Co., Ltd. Report on Issuance of Shares to Purchase Assets and Related Party Transactions (Revised) Summary." It includes extensive information about a major asset restructuring transaction involving issuance of shares to purchase 100% equity of another company, detailed financial data, transaction parties, legal and audit opinions, and compliance with regulatory approvals from the China Securities Regulatory Commission (CSRC). The document discusses the transaction structure, pricing, share issuance, lock-up periods, and related party disclosures. It is a comprehensive disclosure document related to a significant asset acquisition and restructuring by the listed company. This type of document is characteristic of a Capital/Financing Update (CAP) filing, as it provides updates on the company's capital structure changes and financing activities related to the issuance of shares for asset purchase. It is not an Annual Report, Audit Report, or Earnings Release, nor is it a simple announcement or proxy statement. The length and detail confirm it is the report itself, not just an announcement. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2020-06-30 Chinese
发行股份购买资产暨关联交易报告书（修订稿）
Regulatory Filings
2020-06-30 Chinese
关于发行股份购买资产暨关联交易事项获得中国证监会核准的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Zhejiang Huatong Pharmaceutical Co., Ltd. regarding the approval by the China Securities Regulatory Commission (CSRC) for the issuance of shares to purchase assets and related party transactions. It includes details of share issuance to various parties and references regulatory approval and compliance with disclosure obligations. The document is short (1191 characters) and serves as a formal announcement of regulatory approval rather than a full report or detailed financial statement. It does not contain financial statements or detailed analysis but rather informs about the approval and next steps. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes such as share issuance for asset purchase.
2020-06-30 Chinese
浙江浙经律师事务所关于浙农控股集团有限公司、浙江省兴合集团有限责任公司、浙江兴合创业投资有限公司免于发出要约事宜之法律意见书
Audit Report / Information Classification · 95% confidence The document is a legal opinion letter issued by Zhejiang Zhejing Law Firm regarding the exemption from making a tender offer in a share acquisition transaction involving Zhejiang Nong Holding Group Co., Ltd., Zhejiang Xinghe Group Co., Ltd., and Zhejiang Xinghe Venture Capital Co., Ltd. It references relevant Chinese laws such as the Company Law, Securities Law, and the Measures for the Administration of Takeovers of Listed Companies. The document details the qualifications of the acquirers, the conditions for exemption from tender offer, approvals and authorizations, legal obstacles, information disclosure compliance, and the absence of securities violations. It is a standalone legal opinion related to a specific transaction and does not contain financial statements or quarterly/annual financial results. It is not an announcement or a report publication notice but a substantive legal opinion document. Therefore, it fits best under the category of Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles or legal opinions related to regulatory matters, excluding full annual or interim reports. FY 2020
2020-06-30 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.